Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Total Debt (2016 - 2023)

Creative Medical Technology Holdings has reported Total Debt over the past 14 years, most recently at $14194.0 for Q1 2023.

  • Quarterly Total Debt changed 0.0% to $14194.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $14194.0 through Mar 2023, changed 0.0% year-over-year, with the annual reading at $14194.0 for FY2022, 0.0% changed from the prior year.
  • Total Debt was $14194.0 for Q1 2023 at Creative Medical Technology Holdings, roughly flat from $14194.0 in the prior quarter.
  • Over five years, Total Debt peaked at $38.8 million in Q4 2020 and troughed at $11082.0 in Q2 2020.
  • The 5-year median for Total Debt is $26513.5 (2020), against an average of $3.4 million.
  • Year-over-year, Total Debt skyrocketed 23297.7% in 2019 and then tumbled 99.96% in 2021.
  • A 5-year view of Total Debt shows it stood at $6.8 million in 2019, then soared by 466.02% to $38.8 million in 2020, then tumbled by 99.96% to $14194.0 in 2021, then changed by 0.0% to $14194.0 in 2022, then changed by 0.0% to $14194.0 in 2023.
  • Per Business Quant, the three most recent readings for CELZ's Total Debt are $14194.0 (Q1 2023), $14194.0 (Q4 2022), and $14194.0 (Q3 2022).